Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Putative adverse outcome pathways relevant to neurotoxicity.
Bal-Price A, Crofton KM, Sachana M, Shafer TJ, Behl M, Forsby A, Hargreaves A, Landesmann B, Lein PJ, Louisse J, Monnet-Tschudi F, Paini A, Rolaki A, Schrattenholz A, Suñol C, van Thriel C, Whelan M, Fritsche E. Bal-Price A, et al. Among authors: whelan m. Crit Rev Toxicol. 2015 Jan;45(1):83-91. doi: 10.3109/10408444.2014.981331. Crit Rev Toxicol. 2015. PMID: 25605028 Free PMC article. Review.
Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals.
Novellino A, Scelfo B, Palosaari T, Price A, Sobanski T, Shafer TJ, Johnstone AF, Gross GW, Gramowski A, Schroeder O, Jügelt K, Chiappalone M, Benfenati F, Martinoia S, Tedesco MT, Defranchi E, D'Angelo P, Whelan M. Novellino A, et al. Among authors: whelan m. Front Neuroeng. 2011 Apr 27;4:4. doi: 10.3389/fneng.2011.00004. eCollection 2011. Front Neuroeng. 2011. PMID: 21562604 Free PMC article.
Adverse outcome pathway (AOP) development I: strategies and principles.
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M. Villeneuve DL, et al. Among authors: whelan m. Toxicol Sci. 2014 Dec;142(2):312-20. doi: 10.1093/toxsci/kfu199. Toxicol Sci. 2014. PMID: 25466378 Free PMC article.
Adverse outcome pathway development II: best practices.
Villeneuve DL, Crump D, Garcia-Reyero N, Hecker M, Hutchinson TH, LaLone CA, Landesmann B, Lettieri T, Munn S, Nepelska M, Ottinger MA, Vergauwen L, Whelan M. Villeneuve DL, et al. Among authors: whelan m. Toxicol Sci. 2014 Dec;142(2):321-30. doi: 10.1093/toxsci/kfu200. Toxicol Sci. 2014. PMID: 25466379 Free PMC article.
514 results